Asia Pacific Respiratory Inhalers Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product Type [Nebulizers, Metered Dose Inhalers (MDI), and Dry Powder Inhalers], Technology (Manually Operated Inhalers and Digitally Operated Inhalers), and Disease Indication (Asthma, COPD, Pulmonary Arterial Hypertension, and Others)

No. of Pages: 170    |    Report Code: BMIRE00028388    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Asia Pacific Respiratory Inhalers Market

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Asia Pacific Respiratory Inhalers Market – by Product Type

1.3.2        Asia Pacific Respiratory Inhalers Market – by Technology

1.3.3        Asia Pacific Respiratory Inhalers Market – by Disease Indication

1.3.4        Asia Pacific Respiratory Inhalers Market – by Country

2.           Asia Pacific Respiratory Inhalers Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Asia Pacific Respiratory Inhalers Market – Market Landscape

4.1         Overview

4.2         Asia Pacific PEST Analysis

4.3         Expert’s Opinion

5.           Asia Pacific Respiratory Inhalers Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Cases of Respiratory Disorders

5.1.2        Growing Adoption of Generic Inhalers

5.2         Market Restraints

5.2.1        Lack of Early Diagnosis and High Cost of Inhalers

5.3         Market Opportunities

5.3.1        Increasing Adoption of Smart Inhalers Technology

5.4         Future Trends

5.4.1        Increasing Product Development Activities

5.5         Impact Analysis

6.           Respiratory Inhalers Market – Asia Pacific Analysis

6.1         Asia Pacific Respiratory Inhalers Market Revenue Forecast and Analysis

7.           Asia Pacific Respiratory Inhalers Market – Revenue and Forecast to 2028 – by Product Type

7.1         Overview

7.2         Asia Pacific Respiratory Inhalers Market Revenue Share, by Product, 2021 & 2028 (%)

7.3         Dry Powder Inhalers

7.3.1        Overview

7.3.2        Dry Powder Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

7.3.3        Multi-Dose Dry Powder Inhalers

7.3.3.1          Overview

7.3.3.2          Multi-Dose Dry Powder Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

7.3.4        Single Dose Dry Powder Inhalers

7.3.4.1          Overview

7.3.4.2          Single Dose Dry Powder Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Metered Dose Inhalers

7.4.1        Overview

7.4.2        Metered Dose Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

7.4.3        Pressured Metered Dose Inhalers

7.4.3.1          Overview

7.4.3.2          Pressured Metered Dose Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

7.4.4        Connected Metered Dose Inhalers

7.4.4.1          Overview

7.4.4.2          Connected Metered Dose Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

7.5         Nebulizers

7.5.1        Overview

7.5.2        Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

7.5.3        Compressed Air Nebulizers

7.5.3.1          Overview

7.5.3.2          Compressed Air Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

7.5.4        Mesh Air Nebulizers

7.5.4.1          Overview

7.5.4.2          Mesh Air Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

7.5.5        Ultrasonic Air Nebulizers

7.5.5.1          Overview

7.5.5.2          Ultrasonic Air Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

8.           Asia Pacific Respiratory Inhalers Market Analysis and Forecast to 2028 – by Technology

8.1         Overview

8.2         Asia Pacific Respiratory Inhalers Market, by Technology 2021 & 2028 (%)

8.3         Manually Operated Inhalers

8.3.1        Overview

8.3.2        Manually Operated Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Digitally Operated Inhalers

8.4.1        Overview

8.4.2        Digitally Operated Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

9.           Asia Pacific Respiratory Inhalers Market Analysis and Forecast to 2028 – by Disease Indication

9.1         Overview

9.2         Asia Pacific Respiratory Inhalers Market, by Disease Indication, 2021 & 2028 (%)

9.3         Asthma

9.3.1        Overview

9.3.2        Asthma: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

9.4         COPD

9.4.1        Overview

9.4.2        COPD: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

9.5         Pulmonary Arterial Hypertension

9.5.1        Overview

9.5.2        Pulmonary Arterial Hypertension: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

9.6         Others

9.6.1        Overview

9.6.2        Others: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

10.        Asia Pacific Respiratory Inhalers Market – Revenue and Forecast to 2028 – Country Analysis

10.1      Overview

10.1.1     Asia Pacific: Respiratory Inhalers Market, by Country, 2021 & 2028 (%)

10.1.1.1       China: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1       Overview

10.1.1.1.2       China: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.3       China: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)

10.1.1.1.3.1     China: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)

10.1.1.1.3.2     China: Respiratory Inhalers Market, by Metered Dose Inhalers (MDI), 2019–2028 (US$ Million)

10.1.1.1.3.3     China: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)

10.1.1.1.4       China: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)

10.1.1.1.5       China Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)

10.1.1.2       Japan: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1       Overview

10.1.1.2.2       Japan: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.3       Japan: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)

10.1.1.2.3.1     Japan: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)

10.1.1.2.3.2     Japan: Respiratory Inhalers Market, by Metered Dose Inhalers (MDI), 2019–2028 (US$ Million)

10.1.1.2.3.3     Japan: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)

10.1.1.2.4       Japan: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)

10.1.1.2.5       Japan: Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)

10.1.1.3       India: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1       Overview

10.1.1.3.2       India: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.3       India: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)

10.1.1.3.3.1     India: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)

10.1.1.3.3.2     India: Respiratory Inhalers Market, by Metered Dose Inhalers (MDI), 2019–2028 (US$ Million)

10.1.1.3.3.3     India: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)

10.1.1.3.4       India: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)

10.1.1.3.5       India: Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)

10.1.1.4       Australia: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.1       Overview

10.1.1.4.2       Australia: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.3       Australia: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)

10.1.1.4.3.1     Australia: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)

10.1.1.4.3.2     Australia: Respiratory Inhalers Market, by Metered Dose Inhalers (MDI), 2019–2028 (US$ Million)

10.1.1.4.3.3     Australia: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)

10.1.1.4.4       Australia: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)

10.1.1.4.5       Australia: Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)

10.1.1.5       South Korea: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.1       Overview

10.1.1.5.2       South Korea: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.3       South Korea: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)

10.1.1.5.3.1     South Korea: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)

10.1.1.5.3.2     South Korea: Respiratory Inhalers Market, by Metered Dose Inhalers (MDI), 2019–2028 (US$ Million)

10.1.1.5.3.3     South Korea: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)

10.1.1.5.4       South Korea: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)

10.1.1.5.5       South Korea: Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)

10.1.1.6       Rest of Asia Pacific: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.1       Overview

10.1.1.6.2       Rest of Asia Pacific: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.3       Rest of Asia Pacific: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)

10.1.1.6.3.1     Rest of Asia Pacific: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)

10.1.1.6.3.2     Rest of Asia Pacific: Respiratory Inhalers Market, by Metered Dose Inhalers (MDI), 2019–2028 (US$ Million)

10.1.1.6.3.3     Rest of Asia Pacific: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)

10.1.1.6.4       Rest of Asia Pacific: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)

10.1.1.6.5       Rest of Asia Pacific: Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)

11.        Industry Landscape

11.1      Overview

11.2      Inorganic Growth Strategies

11.2.1     Overview

11.3      Organic Growth Strategies

11.3.1     Overview

12.        Company Profiles

12.1      AstraZeneca Plc

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      Beximco Pharmaceuticals Ltd.

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      Boehringer Ingelheim International GmbH

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Cipla Ltd

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      GSK Plc

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Koninklijke Philips NV

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      OMRON Corp

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      PARI Respiratory Equipment, Inc.

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9      Teva Pharmaceutical Industries Ltd

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

12.10   OPKO Health, Inc

12.10.1  Key Facts

12.10.2  Business Description

12.10.3  Products and Services

12.10.4  Financial Overview

12.10.5  SWOT Analysis

12.10.6  Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

 

 

LIST OF TABLES

Table 1.             China Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 2.             China Respiratory Inhalers Market, by Dry Powder Inhalers– Revenue and Forecast to 2028 (US$ Million)

Table 3.             China Respiratory Inhalers Market, by Metered Dose Inhalers (MDI)– Revenue and Forecast to 2028 (US$ Million)

Table 4.             China Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)

Table 5.             China Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 6.             China Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 7.             Japan Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 8.             Japan Respiratory Inhalers Market, by Dry Powder Inhalers– Revenue and Forecast to 2028 (US$ Million)

Table 9.             Japan Respiratory Inhalers Market, by Metered Dose Inhalers (MDI)– Revenue and Forecast to 2028 (US$ Million)

Table 10.          Japan Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)

Table 11.          Japan Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 12.          Japan Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 13.          India Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 14.          India Respiratory Inhalers Market, by Dry Powder Inhalers– Revenue and Forecast to 2028 (US$ Million)

Table 15.          India Respiratory Inhalers Market, by Metered Dose Inhalers (MDI)– Revenue and Forecast to 2028 (US$ Million)

Table 16.          India Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)

Table 17.          India Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 18.          India Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 19.          Australia Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 20.          Australia Respiratory Inhalers Market, by Dry Powder Inhalers– Revenue and Forecast to 2028 (US$ Million)

Table 21.          Australia Respiratory Inhalers Market, by Metered Dose Inhalers (MDI)– Revenue and Forecast to 2028 (US$ Million)

Table 22.          Australia Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)

Table 23.          Australia Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 24.          Australia Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 25.          South Korea Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 26.          South Korea Respiratory Inhalers Market, by Dry Powder Inhalers– Revenue and Forecast to 2028 (US$ Million)

Table 27.          South Korea Respiratory Inhalers Market, by Metered Dose Inhalers (MDI)– Revenue and Forecast to 2028 (US$ Million)

Table 28.          South Korea Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)

Table 29.          South Korea Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 30.          South Korea Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 31.          Rest of Asia Pacific Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 32.          Rest of Asia Pacific Respiratory Inhalers Market, by Dry Powder Inhalers– Revenue and Forecast to 2028  (US$ Million)

Table 33.          Rest of Asia Pacific Respiratory Inhalers Market, by Metered Dose Inhalers (MDI)– Revenue and Forecast to 2028 (US$ Million)

Table 34.          Rest of Asia Pacific Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)

Table 35.          Rest of Asia Pacific Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 36.          Rest of Asia Pacific Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 37.          Recent Inorganic Growth Strategies

Table 38.          Recent Organic Growth Strategies

Table 39.          Glossary of Terms

 

 

LIST OF FIGURES

Figure 1.           Asia Pacific Respiratory Inhalers Market Segmentation

Figure 2.           Asia Pacific Respiratory Inhalers Market, by Country

Figure 3.           Asia Pacific Respiratory Inhalers Market Overview

Figure 4.           Asia Pacific Respiratory Inhalers Market, By Product

Figure 5.           Asia Pacific Respiratory Inhalers Market, By Country

Figure 6.           Asia Pacific: PEST Analysis

Figure 7.           Experts’ Opinion

Figure 8.           Asia Pacific Respiratory Inhalers Market: Impact Analysis of Drivers and Restraints

Figure 9.           Asia Pacific Respiratory Inhalers Market – Revenue Forecast and Analysis

Figure 10.        Asia Pacific Respiratory Inhalers Market Revenue Share, by Product, 2021 & 2028 (%)

Figure 11.        Dry Powder Inhalers: Asia Pacific Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Multi-Dose Dry Powder Inhalers: Asia Pacific Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Single Dose Dry Powder Inhalers: Asia Pacific Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Metered Dose Inhalers: Asia Pacific Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Pressured Metered Dose Inhalers: Asia Pacific Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Connected Metered Dose Inhalers: Asia Pacific Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Nebulizers: Asia Pacific Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Compressed Air Nebulizers: Asia Pacific Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Mesh Air Nebulizers: Asia Pacific Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Ultrasonic Air Nebulizers: Asia Pacific Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Asia Pacific Respiratory Inhalers Market, by Technology 2021 & 2028 (%)

Figure 22.        Manually Operated Inhalers: Asia Pacific Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Digitally Operated Inhalers: Asia Pacific Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.        Asia Pacific Respiratory Inhalers Market, by Disease Indication, 2021 & 2028 (%)

Figure 25.        Asthma: Asia Pacific Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        COPD: Asia Pacific Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Pulmonary Arterial Hypertension: Asia Pacific Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Others: Asia Pacific Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        Asia Pacific: Respiratory Inhalers Market, by Key Country – Revenue (2021) (US$ Million)

Figure 30.        China: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31.        Japan: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32.        India: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33.        Australia: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34.        South Korea: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35.        Rest of Asia Pacific: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

 

The List of Companies - Asia Pacific Respiratory Inhalers Market

  1. AstraZeneca Plc
  2. Beximco Pharmaceuticals Ltd.
  3. Boehringer Ingelheim International GmbH
  4. Cipla Ltd
  5. GSK Plc 
  6. Koninklijke Philips NV
  7. OMRON Corp   
  8. OPKO Health, Inc
  9. PARI Respiratory Equipment, Inc.
  10. Teva Pharmaceutical Industries Ltd